Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure, featuring a bromine at the 6-position and an ethyl carboxylate at the 3-position, allows for selective modification through reactions such as nucleophilic substitution or carbon-carbon bond formation, making it valuable in creating compounds with high biological activity. Commonly employed in medicinal chemistry research to build potent, targeted therapies, especially in oncology drug discovery. Also utilized in the preparation of pyrazolopyridine-based molecules that exhibit anti-inflammatory and central nervous system-modulating effects.